Working groups
Associate Professor Suman Majumdar is Chief Health Officer of COVID & Health Emergencies, a Deputy Program Director (Health Security and Know-C19) and a Principal Research Fellow at Burnet Institute. An infectious diseases physician, public health practitioner and researcher, he has extensive experience in global health and in clinical care and public health in Australia. He has appointments at the Alfred Hospital, Epworth HealthCare and Monash University and served in several leadership roles during the COVID-19 pandemic, including as Deputy Chief Health Officer in the Victorian Department of Health.
Suman aims to contribute to health equity by working in partnership with people, communities, organisations and Governments, integrating care delivery, public health and research. Suman has expertise in infectious diseases and global health security and a focus in the technical areas of tuberculosis and drug-resistance, COVID-19, anti-microbial resistance, and health systems strengthening. He has skills in research (operational and implementation), program design and evaluation, program management and technical direction, training and capacity building and leadership, policy and advocacy. He has experience in in multiple health system contexts, including in Australian urban, rural, tropical medicine and Indigenous health and internationally in Asia, the Pacific, Africa, Central America and Central Asia. Suman co-leads a multidisciplinary and highly collaborative group that aims to generate knowledge and develop solutions to respond to multidrug-resistant TB (MDR-TB) and ultimately, towards ending TB with a focus on the Asia-Pacific region.
Through strong collaboration with Australian and global partners, in particular in PNG, the group has supported the implementation of effective models of care for TB whilst strengthening health systems and building capacity to conduct operational research.
2022 (1)
2021 (10)
COVID-19 Global Trends and Analyses Volume 1:- Global Epidemiology and Trends - Technical Snapshots. (Public Health Report July Update) Toole M, Umali S, Majumdar S. Know-C19 Burnet Institute. August, 2021.
COVID-19 Global Trends and Analyses Volume 2:- Vaccine and Viral Variants Update. (PUBLIC HEALTH REPORT) Toole M, Drummer H, Tachedjian G, Umali S, Majumdar S. Know-C19 Public Health Report. July, 2021.
COVID-19 Global Trends and Analyses Volume 1:- Global Epidemiology and Trends - Research Snapshots. (Public Health Report) Toole M, Umali S, van Gemert-Doyle , Majumdar S. Know-C19 Public Health Report. July, 2021.
COVID-19 Global Trends and Analyses, Volume 2: Vaccines and Viral Variants Update June (PUBLIC HEALTH REPORT) Toole M, Drummer H, Tachedjian G, Umali S, Majumdar S. Know-C19 Public Health Report. July, 2021.
COVID-19 Global Trends and Analyses Volume 2:- Vaccine and Viral Variants Update. May. (PUBLIC HEALTH REPORT) Toole M, Drummer H, Tachedjian G, Umali S, Majumdar S. Know-C19 Burnet Institute. May, 2021.
COVID-19 Global Trends and Analyses Volume 1:- Global Epidemiology and Trends - Science Snapshots. (PUBLIC HEALTH REPORT) Toole M, Umali S, van Gemert-Doyle , Majumdar S. Know-C19 Burnet Institute. May, 2021.
COVID-19 Global Trends and Analyses Volume 1:- Global Epidemiology and Trends - Global Technical. (PUBLIC HEALTH REPORT) Toole M, Umali S, van Gemert-Doyle , Majumdar S. Know-C19 Burnet Institute. April, 2021.
COVID-19 Global Trends and Analyses Volume 2:- Vaccine and Viral Variants Update. April. (PUBLIC HEALTH REPORT) Toole M, Drummer H, Tachedjian G, Umali S, Majumdar S. Know-C19 Burnet Institute. April, 2021.
COVID-19 Global Trends and Analyses Volume 2:- Vaccine and Viral Variants Update - COVID-19 Global Snapshots. (PUBLIC HEALTH REPORT) Toole M, Drummer H, Tachedjian G, Umali S, Majumdar S. Know-C19 Burnet Institute. March, 2021.
2020 (3)
Covid-19 Global Trends and Analysis - Volume 2: SARS-CoV-2 viral load dynamics and infectivity. Tachedjian G, Hearps A, Majumdar S, Toole M, Umali S. Know-C19 Burnet Institute. December, 2020.
China is confronted with a significant challenge in managing a substantial population afflicted with hepatitis B virus (HBV) and hepatitis C virus (HCV). An estimated 93 million individuals live with chronic hepatitis B, while 7 million individuals contend with chronic hepatitis C in China. Moreover, every year, approximately 300,000 deaths are attributed to hepatitis-related diseases in the country.
Overview of viral hepatitis treatment research in China. (WHO Report).The global total number of reported cases is 184 million and the grim milestone of four million deaths has been reached. The cumulative number of cases is equivalent to 23.5 per 1,000 population.
COVID-19 and its impacts on primary health services and public health infectious disease programs in Papua New Guinea. (PUBLIC HEALTH REPORT)As of 2024, 20 more Australians are dying each day as a result of COVID-19. To understand this ongoing problem better, experts at Burnet have developed a comprehensive analysis of deaths caused by the COVID-19 pandemic in Australia. This report evaluates mortality patterns in Australia and comparable countries. We analyse these trends during 2 main periods: the early phase (2020-21) and the later phase (2022 onwards).
COVID-19 pandemic mortality data: reportACS ES&T Air
S. S. Majumdar
Journal of Hazardous Materials
S. S. Majumdar
Social Science & Medicine
S. S. Majumdar, Md Saiful Islam, Stephen Bell, Stephen M. Graham
In 2022-2023, Burnet is facilitating PNG's second Structured Operational Research and Training Initiative (SORT-IT) course, with a cohort of nine senior healthcare professionals from six provinces. The course is implemented in partnership with the National Department of Health, University of PNG, and PNG Institute of Medical Research.
This community-centred public health project will screen all residents of Daru, Papua New Guinea to detect, treat and prevent tuberculosis.
This project aims to strengthen operational research capacity for tuberculosis in Papua New Guinea through structured training, mentorship and research.
This project aims to find out how Victorians are experiencing COVID-19 and responding to the measures introduced to stop the spread of the virus.
This project aims to implement and evaluate a model of community-based drug-resistant tuberculosis care to facilitate scale-up in Myanmar and other similar resource-constrained settings.
This project explores zoonotic tuberculosis—tuberculosis that occurs in animals and is transmitted to humans